These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 22233480)

  • 1. Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products.
    Solomon C; Schöchl H; Hanke A; Calatzis A; Hagl C; Tanaka K; Rahe-Meyer N
    Scand J Clin Lab Invest; 2012 Apr; 72(2):121-8. PubMed ID: 22233480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery.
    Rahe-Meyer N; Solomon C; Winterhalter M; Piepenbrock S; Tanaka K; Haverich A; Pichlmaier M
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):694-702. PubMed ID: 19698858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients.
    Solomon C; Cadamuro J; Ziegler B; Schöchl H; Varvenne M; Sørensen B; Hochleitner G; Rahe-Meyer N
    Transfusion; 2011 Aug; 51(8):1695-706. PubMed ID: 21352237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study.
    Karlsson M; Ternström L; Hyllner M; Baghaei F; Nilsson S; Jeppsson A
    Transfusion; 2008 Oct; 48(10):2152-8. PubMed ID: 18657083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FIBTEM PLUS provides an improved thromboelastometry test for measurement of fibrin-based clot quality in cardiac surgery patients.
    Solomon C; Baryshnikova E; Schlimp CJ; Schöchl H; Asmis LM; Ranucci M
    Anesth Analg; 2013 Nov; 117(5):1054-62. PubMed ID: 24108255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial.
    Rahe-Meyer N; Hanke A; Schmidt DS; Hagl C; Pichlmaier M
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3 Suppl):S178-85. PubMed ID: 23410777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic fibrinogen infusion in cardiac surgery patients: effects on biomarkers of coagulation, fibrinolysis, and platelet function.
    Karlsson M; Ternström L; Hyllner M; Baghaei F; Skrtic S; Jeppsson A
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):396-404. PubMed ID: 20530054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin formation is more impaired than thrombin generation and platelets immediately following cardiac surgery.
    Solomon C; Rahe-Meyer N; Sørensen B
    Thromb Res; 2011 Sep; 128(3):277-82. PubMed ID: 21429567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
    Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative hemostasis and its association with bleeding and blood component transfusion requirements in cardiopulmonary bypass surgery.
    Emeklibas N; Kammerer I; Bach J; Sack FU; Hellstern P
    Transfusion; 2013 Jun; 53(6):1226-34. PubMed ID: 22934739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen concentrate as first-line therapy in aortic surgery reduces transfusion requirements in patients with platelet counts over or under 100×10(9)/L.
    Solomon C; Rahe-Meyer N
    Blood Transfus; 2015 Apr; 13(2):248-54. PubMed ID: 25369608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting.
    Bizzarri F; Scolletta S; Tucci E; Lucidi M; Davoli G; Toscano T; Neri E; Muzzi L; Frati G
    J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1181-5. PubMed ID: 11726894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study.
    Mahla E; Suarez TA; Bliden KP; Rehak P; Metzler H; Sequeira AJ; Cho P; Sell J; Fan J; Antonino MJ; Tantry US; Gurbel PA
    Circ Cardiovasc Interv; 2012 Apr; 5(2):261-9. PubMed ID: 22396581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery.
    Solomon C; Pichlmaier U; Schoechl H; Hagl C; Raymondos K; Scheinichen D; Koppert W; Rahe-Meyer N
    Br J Anaesth; 2010 May; 104(5):555-62. PubMed ID: 20348140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
    Andreasen JJ; Nielsen C
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery.
    Solomon C; Hagl C; Rahe-Meyer N
    Br J Anaesth; 2013 Jun; 110(6):947-56. PubMed ID: 23388508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery.
    Blome M; Isgro F; Kiessling AH; Skuras J; Haubelt H; Hellstern P; Saggau W
    Thromb Haemost; 2005 Jun; 93(6):1101-7. PubMed ID: 15968395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiopulmonary bypass copolymer surface modification reduces neither blood loss nor transfusions in coronary artery surgery.
    Südkamp M; Mehlhorn U; Reza Raji M; Hekmat K; Easo J; Geissler HJ; Sindhu D; de Vivie R
    Thorac Cardiovasc Surg; 2002 Feb; 50(1):5-10. PubMed ID: 11847596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.